Dermatitis clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

    Sorry, not currently recruiting here

    This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety of camoteskimab in adults with moderate to severe AD.

    Los Angeles, California and other locations

Last updated: